Insider trade

Doximity (DOCS)Director sold ~$354K

Regina M. Benjamin, Director at Doximity, sold ~$354K of Doximity shares.

~$354K
Approx. value · 5,000 sh @ $70.84
20K
Holds after · shares reported
Traded
Oct 10, 2025
Filed
Oct 15, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 8, 2025InsiderDirector sold ~$315K of DOCS shares in the open market
  2. Aug 15, 2025Insider · 1 personInsiders: 2 sales (~$1.3M)
  3. Aug 25, 2025CongressDisclosed purchase of DOCS — reported range $15,001 - $50,000
  4. Aug 26, 2025InsiderCFO sold ~$2.67M of DOCS shares in the open market
  5. Sep 2, 2025Insider · 2 peopleInsiders: 2 sales (~$555K)
  6. Sep 12, 2025InsiderDirector sold ~$353K of DOCS shares in the open market
  7. Sep 24, 2025Insider · Their largest sale since 2023Director sold ~$1.5M of DOCS shares in the open market
  8. Oct 10, 2025 · this disclosureInsiderDirector sold ~$354K of DOCS shares in the open market

What came next

  1. Nov 3, 2025InsiderDirector sold ~$133K of DOCS shares in the open market
  2. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
  3. Nov 6, 2025CongressDisclosed sale of DOCS — reported range $15,001 - $50,000
  4. Nov 21, 2025InsiderDirector sold ~$500K of DOCS shares in the open market
  5. Dec 1, 2025InsiderDirector sold ~$101K of DOCS shares in the open market
  6. Jan 2, 2026InsiderDirector sold ~$89K of DOCS shares in the open market
  7. Feb 2, 2026InsiderDirector sold ~$75K of DOCS shares in the open market
  8. Feb 3, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“On February 5, 2026, Doximity, Inc. (“Doximity” or the “Company”) announced that Anna Bryson, the Company’s Chief Financial Officer, principal financial officer, and principal accounting officer, is taking a temporary medical leave of absence.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Doximity

For Doximity, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DOCS page.

Other recent filings by Regina M. Benjamin, Director

The full history of Regina M. Benjamin, Director is on the profile page.

How this filing works

Other disclosures at Doximity

Everything OQRO holds on this company is on its DOCS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data